Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing...
The Device Talks podcast spotlighted the emerging field of telesurgical stroke treatment, exploring how remote thrombectomy could dramatically shorten the critical "time‑is‑brain" window. Host Tom Slumby and guests examined a nascent competitive landscape, highlighting six innovators racing to bring remote neuro‑vascular procedures to market. Key insights included the absence of an FDA‑cleared U.S. product, the strategic use of the FDA’s TAP program, and the varied technical approaches—from XCAT’s proven 100‑mile remote thrombectomy in Panama to Nanoflex’s electromagnetic wire‑steering concept. Companies such as Remedy Robotics, Microbot Medical, and Cente showcased pilot studies in Canada and other international sites, underscoring a global push to validate safety and efficacy. Notable examples featured XCAT’s long‑distance procedure, Remedy Robotics’ cross‑country neuro‑intervention trial, and Cente’s haptic joystick that mimics tactile feedback for remote surgeons. The editorial team framed the sector as a race, prompting each firm to articulate why they could win, which added a sports‑like narrative to traditionally technical coverage. The race narrative could accelerate funding, regulatory engagement, and clinical adoption, potentially delivering life‑saving technology to stroke patients faster than traditional pathways. If successful, remote thrombectomy may reshape emergency care logistics, expand market opportunities for medtech firms, and set a precedent for other telesurgical applications.
Lisa Earnhardt on Abbott’s Innovation Strategy and the Future Of...
The latest Device Talks weekly podcast opened with a preview of Lisa Earnhardt’s closing keynote at Device Talks Minnesota, where the Abbott executive outlined the company’s open‑platform innovation strategy aimed at accelerating personalized health solutions. Earnhardt stressed that sharing...
A Focused View of EDOF™ Technology From a GI Clinician
The Olympus podcast spotlights the EVIS X1 1500 series, emphasizing its Extended Depth of Field (EDOF) technology. Host Tom Salmi and Olympus specialist Amanda Call discuss how the new imaging suite—featuring TXI, RDI, and a CMOS sensor—addresses longstanding challenges in...
DeviceTalks Boston Preview Episode – Four of the Many Amazing Voi...
The episode serves as a preview for Device Talks Boston, a two‑day med‑tech conference on May 27‑28 at the Boston Convention & Exhibition Center. Host Tom Salmi urges listeners to register using code DTW25 for a 25 % discount and highlights the...
Perfuze CEO Lays Out the Challenge – and the Promise – of Buildin...
The latest Device Talks weekly podcast recapped the successful Minnesota gathering and turned its focus to the upcoming Device Talks Boston conference, slated for May 27‑28. Organizers highlighted a 25% early‑bird discount (code DTW25) and a packed agenda featuring keynotes, panels...
Patients Are the Co-Designer — Plexāā’s Gaele Lalahy
The Women in MedTech podcast episode features Gail Lalahy, COO of Plexa, discussing the company's 'patient as co‑designer' philosophy behind its Bloom device and how that approach reshapes product development. Plexa has institutionalized a rule that no decision proceeds without patient...
OrthAlign CEO Eric Timko on the Opportunity for Fast Followers In...
The Device Talks podcast episode provides a broad snapshot of the current med‑tech landscape, from regulatory shifts and financing to cybersecurity and market growth. Host Tom Le and guests discuss recent events such as the MedTech Innovator Radar Forum, FDA...
New Pharaoh CEO Amaza Reitmeier Explains Why Now’s the Time to Ta...
The Device Talks episode centers on Amaza Reitmeier, the newly appointed CEO of Pharaoh Neuro, who explains why the company believes the current moment is optimal for advancing its neuro‑technology platform. Reitmeier, a former Medtronic executive, details her decision to...
Can Abbott’s Connected Neuromodulation Platforms Improve Life For...
The latest Abbott Talks podcast episode spotlights Abbott’s connected neuromodulation platform, a suite of implantable devices that communicate wirelessly with clinicians, electronic health records and AI‑driven decision tools. Host Tom Salmi and guests, including R&D vice‑president Rebecca Wilkins, discuss how...
CEO Stephen From Is Building Tested Strategies Into a New Plan To...
The episode centers on Stephen, the newly appointed CEO of Vicarius Surgical, who argues that the company should be viewed primarily as a medical‑device firm rather than a pure robotics play. He outlines a “tested strategies” framework that prioritizes regulatory...
How Generative AI Can Make Diabetes Care Proactive, Not Reactive
Dexcom CTO Girish Naganathan highlights that behavior change remains the toughest hurdle in diabetes care. By pairing continuous glucose monitoring (CGM) with generative AI, raw glucose data can be transformed into real‑time, actionable recommendations. The technology aims to shift guidance...
Armor Medical’s Wearable Could Give Earlier Warnings of Severe He...
The episode centers on Armor Medical’s breakthrough wearable, which earned the company the grand prize at the MedTech Innovator competition. Host Tom Salmi interviews CEO Kelsey Mayo, highlighting how the sensor could alert patients and clinicians to impending severe health...
Neurotechnology’s Role Beyond Drugs in Treating Brain Disorders
The video spotlights neurotechnology as a burgeoning alternative to pharmaceuticals for brain‑disorder treatment, emphasizing its capacity to directly modulate neural activity without crossing the blood‑brain barrier. Speakers highlight that synchronized light and sound—so‑called sensory ramps—can activate brain circuits, while brain‑computer interfaces,...
Pulsed Field Ablation Shows Early Promise for VT Treatment
The video discusses the first prospective trial of pulsed‑field ablation (PFA) applied to ventricular tachycardia (VT), a technique previously limited to atrial procedures. Published in Circulation: Arrhythmia and Electrophysiology, the study marks a milestone in expanding PFA to the ventricle. Results...
Why Integrated Technology Matters in Outpatient Surgery
The video spotlights why integrated technology is essential for outpatient surgery, drawing on the speaker’s experience as a physician, investor, and policy‑tech analyst. He observes a fragmented landscape where rising costs and misaligned incentives between volume and value hinder patient...